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Bone developmentMicroRNA attenuation of protein translation has emerged as an important regulator of mesenchymal cell
differentiation into the osteoblast lineage. A compelling question is the extent to which miR biogenesis is
obligatory for bone formation. Here we show conditional deletion of the Dicer enzyme in osteoprogenitors by
Col1a1-Cre compromised fetal survival after E14.5. A mechanism was associated with the post-commitment
stage of osteoblastogenesis, demonstrated by impaired ECMmineralization and reduced expression of mature
osteoblast markers during differentiation of mesenchymal cells of ex vivo deleted Dicerc/c. In contrast, in vivo
excision ofDicer byOsteocalcin-Cre inmature osteoblasts generated a viablemousewith a perinatal phenotype
of delayed bonemineralization which was resolved by 1 month. However, a second phenotype of signiﬁcantly
increased bonemass developed by 2 months,which continued up to 8 months in long bones and vertebrae, but
not calvariae. Cortical bone width and trabecular thickness in DicerΔoc/Δoc was twice that of Dicerc/c controls.
Normal cell and tissue organization was observed. Expression of osteoblast and osteoclast markers
demonstrated increased coupled activity of both cell types. We propose that Dicer generated miRs are
essential for two periods of bone formation, to promote osteoblast differentiation before birth, and control
bone accrual in the adult., University of Massachusetts
01655, USA. Fax: +1 508 856
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
For normal development of a mineralized skeleton and renewal of
bone throughout life, membranous and endochondral bone formation
is tightly regulated by osteogenic signaling pathways (Wnt, TGFβ/
BMP, Notch) and transcription factors directing cell speciﬁcation
(Lian et al., 2006; Soltanoff et al., 2009). Following commitment of
mesenchymal stem cells to osteoprogenitors, further differentiation
requires the temporal activation of genes coding proteins responsible
for forming the bone ECM, promoting mineralization and supporting
the metabolic activities of osteoblasts. Gene regulatory mechanisms
essential for bone formation have been elaborated in relation to
epigenetic and chromatin alteration of the gene, post-transcriptional
control of mRNA from splice variants and post-translational biochem-
ical modiﬁcations of protein activity. MicroRNA (miR), are small non-
coding RNA molecules that regulate gene expression through post-
transcriptional degradation or translational inhibition by binding totheir target mRNAs. The regulatory function of miRs in controlling
levels and/or translation of target mRNAs during in vivo bone forma-
tion has not been examined.
Only a small number ofmiRs that function during skeletal develop-
ment and in relation to disease have been identiﬁed (Kobayashi et al.,
2008; Li et al., 2009; Luzi et al., 2008; Mizuno et al., 2008a; Nakasa
et al., 2008). MicroRNAs have been characterized in bone and cartilage
and in association with rheumatoid arthritis synovial tissue (Kobaya-
shi et al., 2008; Li et al., 2008b; Luzi et al., 2008; Mizuno et al., 2008b;
Nakasa et al., 2008; Tuddenham et al., 2006). Signiﬁcantly, two studies
identiﬁed miRs which were both modulated at the onset of induced
osteoblastogenesis by BMP2 in humanmesenchymal stromal cells and
C2C12myogenic cells (Li et al., 2008b; Oskowitz et al., 2008). Proﬁling
of BMP2 during bone formation in vivo (Kobayashi et al., 2008) and
during stages of osteoblast differentiation in vitro (Li et al., 2009) has
also implicated mature miRs in the regulation of transcripts that
contribute to skeletal activities. In addition to these studies in bone
forming osteoblasts, miRs regulating the bone resorbing osteoclasts
are now known (Sugatani and Hruska, 2009). These ﬁndings raise a
compelling question as to the requirement for miRs contributing to
activation of bone formation and regulating suppression of the osteo-
blast phenotype in non-osseous cells. Here we addressed whether
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of osteoblast function in vivo.
One approach for understanding tissue speciﬁc requirements for
miRs is the conditional deletion of the enzymes Drosha and Dicer
(Bernstein et al., 2003). Drosha processes the primary miRNAs
encoded in genes to 60–70 nucleotide long precursor miRNA (pre-
miRNA) in the cytoplasm which are recognized and cleaved by an
RNase III endonuclease protein, Dicer, to generate 21–23 nucleotide
mature miRNAs that assemble into a ribonucleoprotein silencing
complex (RISC) to bind to 3′ untranslated region (UTR) of the target
mRNAs (Jaskiewicz and Filipowicz, 2008). Dicer plays a critical role in
a vast range of physiologic processes, including embryonic develop-
ment, cell growth and phenotype differentiation through regulation
of microRNA maturation (Blakaj and Lin, 2008). Dicer functions
are essential for embryo development and survival as a Dicer-null
mouse (Bernstein et al., 2003) and a hypomorphic Dicermutant (Yang
et al., 2005) results in lethality in the ﬁrst week of embryogenesis.
Thus, conditional ablation of Dicer activity has been studied in various
tissues, demonstrating a pivotal role of Dicer-dependent processing of
microRNAs for cell fate speciﬁcation, differentiation and tissue
morphogenesis in all the tissues examined, among which include
skin follicles, heart, brain, immune cells, lung, spermatogenesis and
female germline cells (Andl et al., 2006; Chen et al., 2008; Cobb et al.,
2005; da Costa Martins et al., 2008; Damiani et al., 2008; Davis et al.,
2008; Harris et al., 2006; Harvey et al., 2008; Hayashi et al., 2008;
Kanellopoulou et al., 2005; Koralov et al., 2008; Muljo et al., 2005;
Murchison et al., 2007; Nagaraja et al., 2008; O'Rourke et al., 2007;
Schaefer et al., 2007; Yi et al., 2006).
Limited information is available for Dicer and microRNA require-
ments during skeletal development. Limbmesoderm-speciﬁc deletion
of Dicer using prx1-Cre in mice resulted in massive cell death and
reduction in size, but did not affect skeletal patterning (Harfe et al.,
2005). However, the requirement for Dicer processed mature miRs in
bone tissue has remained unexplored. In this study, excision of Dicer
in mice was performed at two stages of bone formation using Col1a1-
Cre and Osteocalcin (OC)-Cre which resulted in distinct phenotypes
identifying different requirements for miR biogenesis. Ablation of
Dicer in osteoprogenitors (using Col1a1-Cre for conditional deletion)
prevents their differentiation and compromises fetal survival at E15.5.
OC-Cre excision of Dicer delays perinatal bone formation which is
resolved during post-natal growth. However, in DicerΔoc/Δoc adult
mice a striking increase in both trabecular and cortical bone mass was
found. This deregulated increase in bone tissue formation was
accompanied by a coupled increase in bone resorption to support
vascularization of the thickened bone. A contributing mechanism to
this anabolic phenotype is the increased synthesis of bone matrix
proteins including collagen type I, a target of several microRNAs in
osteoblasts. Our studies establish that miRs are required to initiate
osteoblast maturation during development and to regulate bonemass
in adult mice.Materials and methods
Conditional excision of Dicer
For conditional deletion of Dicer, Dicerc/c mice (Mudhasani et al.,
2008) were crossed with Col1a1-Cre (2.3 kb promoter of collagen
type I) (Liu et al., 2004) and OC-Cre (Osteocalcin) (Chiang et al., 2009;
Yuan et al., 2008) mouse line obtained from Dr. Thomas Clemens
(University of Alabama at Birmingham, AL). Dicerc/c mice were
crossed with Ink4a/Arf−/− mice for deletion of the Ink4a/Arf locus to
obtain senescence-resistance (Serrano et al., 1996). The mice were
maintained at the University of Massachusetts by IACUC approved
procedures. Genotyping was carried out as previously described
(Chiang et al., 2009; Liu et al., 2004; Mudhasani et al., 2008).MicroCT (µCT) analysis
MicroCT analysis was performed by the University of Massachusetts
Medical School Musculoskeletal Center for Imaging Core facility. Bones
were ﬁxed in periodate-lysine-paraformaldehyde (PLP) ﬁxative (Miao
and Scutt, 2002) from Dicerc/c and DicerΔoc/Δoc mice. After dehydration
to 70% alcohol, femurswere scanned at 10 µmvoxel resolution (µCT 40;
Scanco Medical AG, Bruttisellen, Wangen-Brüttisellen, Switzerland).
Image reconstruction was performed by Scanco software version 5.0.
For trabecular bone 100 contiguous slices below the growth plate were
selected for contouring inside the endosteal edge for analyses of various
bone parameters. Cortical parameters were analyzed from 50 cross-
sectional slices at the mid-diaphysis region. Parameters were obtained
using threshold range 220–1000.
Skeletal staining and histology
Whole skeletal staining was performed by standard procedures
using Alcian blue and Alizarin red stains for cartilage and bone tissue
(Lufkin et al., 1992). Separate embryos, day 2 pups of femurs from 2
mo old mice were ﬁxed in PLP, parafﬁn-embedded, and sequential
staining of sections was performed by von Kossa stain for mineral and
Toluidine blue for cellular detail. Cytochemical detection of bone-
speciﬁc alkaline phosphatase (Alk Phos) and osteoclast-speciﬁc
tartrate resistant acid phosphatase (TRAP) was performed (Lengner
et al., 2004). Images were captured using a Zeiss Axioskop 40 (Mikron,
San Marcos, CA, USA) microscope with a CCD camera.
Ex vivo osteoblast differentiation
Bonemarrow stromal cells (BMSC)were isolated fromDicerc/c mice
in αMEM supplemented with 20% fetal bovine serum (Hyclone, Logan,
UT, USA). Cells were transduced at 60% conﬂuency with Ad-Cre or Ad-
GFP (control virus) for 3 h for excision of Dicer, then cultured in αMEM
with 50 µg/ml ascorbic acid and 10 mM β-glycerol phosphate (SIGMA-
Aldrich, St. Louis, MO, USA) to induce the osteoblast differentiation.
Calvarial osteoblasts were isolated from newborn DicerΔoc/Δoc by
collagenase P digestion, genotyped and cultured for osteoblast differen-
tiation (Pratap et al., 2003). Cells were harvested at indicated time
points for Alk Phos activity, mineral staining, and gene expression
analyses. Staining for senescence-associated β-Galactosidase (SA-βGal)
was performed by a standard procedure (Dimri et al., 1995). Excision
of Dicer was detected by PCR with forward (5′-CCGACCAGCCTTGT-
TACCTG-3′) and reverse primers (5′-CGGTGTTTCCTTTGAATACTT-3′)
using GAPDH as internal control (Applied Biosystems). Experiments
were repeated at least twice with similar results.
RNA isolation and quantitative real time PCR
Cells were harvested in 300 µl TRIzol reagent (Invitrogen, Carlsbad,
California, USA). Total RNA isolated as per the manufacturer's
instructions (Invitrogen, Carlsbad, California, USA) and treated with
RNase-free DNase. The reverse transcription reaction was performed
on 1 µg of RNA using the First Strand Synthesis Kit (Invitrogen,
Carlsbad, California, USA). Relative transcript levels weremeasured by
quantitative PCR in 25 µl reaction volume using ABI PRISM 7300
sequence detection system (Applied Biosystems, Foster City, CA, USA),
following the recommended protocol for SYBR-Green, and normalized
with GAPDH levels (Applied Biosystems, Foster City, CA, USA). The
primers used for ampliﬁcation are described in Table 1.
For detection of let-7a and miR-29b, mirVANA qRT-PCR miRNA
detection kit along with primer sets for each microRNA (Applied
Biosystems/Ambion, Foster City, CA, USA) were used, following the
manufacturer's procedure. The miR levels were normalized using U6
primers.
Table 1
List of primers used for quantitative real time PCR.
Gene Primer sequence
Runx2 For 5′ CGCCCCTCCCTGAACTCT 3′
Rev 5′ TGCCTGCCTGGGATCTGTA 3′
Alkaline phosphatase For 5′ TTGTGCGAGAGAAAGGAGA 3′
Rev 5′ GTTTCAGGGCATTTTTCAAGGT 3′
Osteocalcin For 5′ CTGACAAAGCCTTCATGTCCAA 3′
Rev 5′ GCGCCGGAGTCTGTTCACTA 3′
Collagen1a1 For 5′ CCCAAGGAAAAGAAGCACGTC 3′
Rev 5′ AGGTCAGCTGGATAGCGACATC 3′
Collagen1a2 For 5′ GTCCTAGTCGATGGCTGCTC 3′
Rev 5′ CAATGTCCAGAGGTGCAATG 3′
Collagen3a1 For 5′ AGGCCAGTGGCAATGTAAAG 3′
Rev 5′ CTCCATTCCCCAGTGTGTTT 3′
Collagn5a3 For 5′ AGGGACCAACTGGGAAGAGT 3′
Rev 5′ AAAGTCAGAGGCAGCCACAT 3′
Bone sialoprotein For 5′ GCACTCCAACTGCCCAAGA 3′
Rev 5′ TTTTGGAGCCCTGCTTTCTG 3′
Osteopontin For 5′ ACTCCAATCGTCCCTACAGTCG 3′
Rev 5′ TGAGGTCCTCATCTGTGGCAT 3′
TRAP ABI mm00475698_m1
RANKL ABI mm00437135_m1
Dicer For 5′ GGTGGTTCGTTTTGATTTGCC 3′
Rev 5′ GGCAGTGTTGATTGTGACTC 3′
p21 For 5′ TTGCACTCTGGTGTCTGAGC 3′
Rev 5′ TCTGCGCTTGGAGTGATAGA 3′
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In vivo deletion of Dicer in hypertrophic chondrocytes and osteoblast
lineage cells induces embryonic lethality
To establish the role of Dicer-dependent miRs in bone growth and
differentiation, we used a Dicer conditional mouse model (Dicerc/c) in
which Cre-mediated excision leads to deletion of the Dicer PAZ do-
main (Mudhasani et al., 2008). The collagen type 1 (2.3 kb) promoter
driving Cre recombinase (Col1a1-Cre) which is robustly expressed in
committed osteoprogenitors, osteoblasts and hypertrophic chondro-
cytes (Liu et al., 2004) was used to address Dicer functions during
skeletal development. Because no live mice with homozygous dele-
tion of Dicer were recovered at birth, embryos were examined for
skeletal deformities. At E14.5 Cre-positive DicerΔcol1/Δcol1 fetal pups
represented 24% of the total population of 49 embryos from 8 litters
and were smaller but viable (Fig. 1A, upper panels). Skeletal staining,
however, revealed a deformed cartilage skeleton without bone tissue
in DicerΔcol1/Δcol1, whereas Dicerc/c embryos showed early bone
formation (Fig. 1A, lower panels). E15.5 DicerΔcol1/Δcol1 pups
represented 23% of the population but were partly resorbed
(Fig. 1B). Thus, after E14.5 fetal survival is compromised by Dicer
excision.
We analyzed cellular details of Dicerc/c and DicerΔcol1/Δcol1 fetal
pups to identify speciﬁc functions of Dicer during embryonic bone
development. In control mice at E14.5 (Fig. 1C) intramembranous and
endochondral bone formation was detected by mineral deposition
and alkaline phosphatase (Alk Phos) positive osteoblasts and hyper-
trophic chondrocytes in themandible, clavicles and ribs (Fig. 1D, 1–4).
In DicerΔcol1/Δcol1 embryos, bone tissue was either completely absent
or signiﬁcantly reduced as reﬂected by fewer Alk Phos positive cells.Fig. 1. In vivo excision of Dicer by Col1a1-Cre impairs bone formation at E14.5 and
induces embryonic lethality. (A) Skeletal deformities observed at E14.5. Upper panel
shows smaller but viable DicerΔcol1/Δcol1 embryos at E14.5. Alcian blue/Alizarin red
staining (lower panel) reveals lack of mineralizing clavicles (see arrow in Dicerc/c and
Dicerwt/Δcol1) and a deformed cartilaginous skeleton in DicerΔcol1/Δcol1. (B) Images of
E15.5 fetal pups show partial resorption of DicerΔcol1/Δcol1 pup. (C) Embryo sections are
compared at E14.5 and (D) detailed (boxed areas) at higher magniﬁcation for Dicerc/c
(1–4) and DicerΔcol1/Δcol1 (5–8), showing severely impaired mineralization of mandible
mesenchyme that surrounds Meckel's cartilage (1, 5), clavicle (2, 6) and reduced Alk
Phos staining in the lower jaw (3, 7) and ribs (4, 8) of DicerΔcol1/Δcol1 embryos.Mineralized tissue formation appears to be compromised as no von
Kossa stainingoccurred in cartilaginousor osseous tissues (Fig. 1D, 5–8).
Thus, Dicer ablation by Col1a1-Cre inhibits further differentiation of
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induction of mineralizing elements in control mice.
Fetal lethality at the onset of bone formation that results from lack
of Dicer in Col1a1 expressing cells may be due in part because
a marrow cavity, which supports hematopoiesis, is not formed.
Alternatively, bone formation may only be delayed in the absence of
Dicer; however, lethality at E15.5 does not allow this assessment. We
conclude that loss of miR processing at E14.5 prevents maturation to
hypertrophic chondrocytes and osteoblasts that results in failure to
produce mineralized matrices.
Ex vivo deletion of Dicer abrogates miR processing and results in
defective osteoblast differentiation
To identify the stage of osteoblastogenesis blocked in DicerΔcol1/Δcol1
mice, bonemarrow stromal cells (BMSCs) fromDicerc/cmice at 8 weeks
were differentiated into the osteoblast lineage. Following transduction
of BMSCs by adenovirus Cre (Ad-Cre), the Dicer locus showed >90%
excision (Fig. 2A). To conﬁrm loss of miRs, we examined miR-29b and
let-7a expression (Fig. 2B), which are known to inﬂuence osteoblast
differentiation and tissue formation (Harfe et al., 2005; Li et al., 2009).
We ﬁnd that in differentiating control Ad-GFP cells, miR-29b and let-7a
are upregulated at the matrix maturation stage (day 19) and down-
regulated during mineralization (day 27). In Dicer-ablated cells, let-7a
levels were suppressed throughout differentiation (Fig. 2B), indicating
loss of miRs in the absence of Dicer. No difference in cellularity was
observed between Ad-GFP and Ad-Cre treated cells from initial plating
to conﬂuency, as shown by Toluidine blue staining at day 5 (Fig. 2C)
and normal expression of histone H4 RNA (Supplementary Fig. S1A).
Also, pro-apoptotic Bax and anti-apoptotic Bcl2 were expressed at
comparable levels in both Ad-GFP control and Ad-Cre treated samples
(Supplementary Fig. S1B) suggesting normal growth and survival
properties in absence of Dicer in BMSCs. While control cells exhibited
the normal differentiation proﬁle of increased Alk Phos and ECM
mineralization (Fig. 2C, upper panels), BMSCs lackingDicer activity (Ad-
Cre) showedmarkedly reducedAlkPhos activity andmineral deposition
as early as day 12, reﬂecting failed maturation (Fig. 2C, lower panels).
The mechanism of inhibited differentiation was interrogated by
examining expressionof genes that contribute to osteoblastmaturation.
Runx2, the early marker of a committed osteoblast, and Col1a1 are
equivalently expressed between Ad-GFP and Ad-Cre cultures at day
12 and 19 (for Col1a1). However, neither Runx2 nor Col1a1 is further
upregulated in Ad-Cre cells as differentiation progresses (Fig. 2D).
Markers related to mineral deposition, Alk Phos, Osteopontin (OP),
Osteocalcin and Bone sialoprotein (BSP) were not induced in Dicer-
ablated cells (Fig. 2D). Our results show that osteoblast defects occur
after cells are committed to the bone phenotype by Runx2; thus,
evidence is provided that commitment and proliferative expansion of
osteoprogenitors are not affected by Dicer excision in BMSCs. These
ﬁndings suggest that a group of miRs processed by Dicer are required
for maturation to the fully differentiated osteoblast phenotype.
Absence of Dicer induces differentiation defects independent of
cell senescence
Recent reports indicate an increase in senescence of mouse
embryonic ﬁbroblasts upon Dicer deletion (Mudhasani et al., 2008).
To explore the possibility of a similar secondary effect in BMSCs, we
performed senescence-associated β-Gal staining on growing cells
after Dicer excision by Ad-Cre. Increased senescence was observed in
Dicer-ablated cells compared to control cells by histochemical staining
(Fig. 3A, left panel) and conﬁrmed by 2.4 fold higher expression of
p21, a marker of senescence (Fig. 3A, right panel). To exclude a role for
cell senescence in reduced osteogenesis of Dicer-ablated cells, BMSCs
were obtained from Dicerc/c; Ink4a/Arf−/− mice for osteoblast dif-
ferentiation following treatment with Ad-GFP (control) and Ad-Cre.Analyses were performed on day 7 post infection. An 80% reduction of
DicermRNA was found in BMSCs infected with Ad-Cre (Fig. 3B). Also,
p21 expression by qRT-PCR conﬁrmed that osteoblast cell senescence
is not affected by Dicer excision in BMSCs from senescence-resistant
mice (Fig. 3B). Dicer-ablated BMSCs could not undergo matrix
maturation and mineralization based on inhibited Alk Phos, mineral
deposition, andOCmRNA levels (Fig. 3B). Thus, removal of senescence
did not rescue Dicer-induced differentiation defects. This strengthens
the conclusion that defects in osteoblast differentiation are not sec-
ondary to premature cell death, but are directly related to absence of
miRs.
Deletion of Dicer in osteoblasts and osteocytes delays perinatal bone
formation
Osteocalcin is highly expressed in mature surface osteoblasts and
osteocytes. To further explore in vivo mechanisms for Dicer control of
bone formation duringmineralization, we inactivated Dicer by OC-Cre
which is robustly expressed in mature osteoblasts in a matrix
undergoing active deposition of mineral (Chiang et al., 2009; Yuan
et al., 2008). DicerΔoc/Δoc mice were viable, with no apparent skeletal
defects at birth by skeletal staining and radiography (data not shown).
Femur histology (day 2 mice) showed normal cellular organization of
the growth plate and bone formation (data not shown). However,
we observed a delay in endochondral bone formation in the tail
vertebrae, which are the last bones to develop. DicerΔoc/Δoc vertebrae
had fewer hypertrophic chondrocytes and weaker Alk Phos activity in
the bone collar compared to Dicerc/c (Fig. 4A, 1, 2). Therefore, we
examined the fetal skeleton at E17.5 and found that the craniofacial
region and ribs displayed strikingly reduced Alk Phos activity in
DicerΔoc/Δoc (Fig. 4A, 3–6). These results suggest delayed bone
formation and an inherent defect in osteoblastogenesis.
Cellular mechanisms for DicerΔoc/Δoc induced bone defects were
examined by ex vivo differentiation of calvarial osteoblasts from
newborn mice. A severe reduction in Alk Phos activity was observed
after day 14,while control Dicerc/c calvarial cells reachedpeak levels in
activity andmRNA (Figs. 4B, C). Signiﬁcantly, DicerΔoc/Δoc cells showed
no induction of Runx2 and Osterix, two transcription factors essential
for further differentiation. In contrast, expression of Col1a1, the major
bone protein was upregulated in Dicer-ablated cells (Fig. 4C), con-
sistent with the decrease in let-7a (Fig. 4C) which targets collagens
(Li et al., 2009). A block in osteoblast differentiation occurs at the
mineralization stage as reﬂected by lack of OC expression after day 14
(Fig. 4C). All the markers except Col1a1 were at normal levels in
proliferating cells, whenOC promoter activity driving Cre expression is
at low basal levels. These ﬁndings are analogous to ex vivo excision
of Dicerc/c BMSCs (Fig. 2). Thus, mechanisms controlled by Dicer in
mature osteoblasts support post-transcriptional regulation of target
genes through miRs that are essential for mineralization of the bone
ECM. Such targets would include well-characterized enzymes and
matrix proteins (Li et al., 2009).
Dicer excision in mature osteoblasts/osteocytes increases bone mass in
adult mice
Mice after birth were continuously monitored up to 8 months and
exhibited similar growth rates (data not shown). Unlike the severe
defects observed at late gestation in DicerΔoc/Δoc mice, radiography
revealed that bone formation after birth (post-natal day 2 and
4 weeks age) was normal (data not shown). However, at 2 months of
age increased radio-opacity was observed in femurs, spine and tail
vertebrae in DicerΔoc/Δoc compared to the Dicerc/c mice (Supplemen-
tary Fig. S2). Cortical bone width increased and trabecular bone of the
vertebrae became very dense. Interestingly, no differences could be
observed in radiographs of calvarial bones at 2 months of age between
Fig. 2. Contributing mechanisms for defective osteoblast differentiation in the absence of Dicer. Dicer excision in BMSCs from Dicerc/c mice by Ad-Cre, followed by differentiation into
osteoblasts. Ad-GFP was used as control for transduction of cells. (A) Genomic PCR of Ad-GFP (control) and Ad-Cre treated cells identiﬁed >90% excision of Dicer locus on day 5
(GAPDH, internal control). (B) Lack of miR-29b (red lines) and let-7a (blue lines) expression in the absence of Dicer. Solid lines (——) show control Ad-GFP treated cells; dashed lines
(---), Ad-Cre Dicer-ablated cells. (C) Cellularity (Tol blue) was not affected by Dicer excision, but differentiation (Alk Phos activity) and mineral (von Kossa stain) were severely
impaired. (D) Expression patterns of early markers of committed osteoprogenitors, Runx2 and Col1a1, and components for the onset and regulation of mineralization by the non-
collagenous proteins, OC, BSP and OP, reﬂect impaired maturation of osteoblasts in Dicer-excised (Ad-Cre) cells.
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calvariae were not characterized further by µCT for detailed analyses.
At 1, 2, 4 and 8 months of age, cortical and trabecular bone struc-
ture of femurs was evaluated by µCT analysis (Fig. 5). Single sagittal
sections show increasing trabecular thickness (Fig. 5A) and widened
cortex (Fig. 5C) from2 to 8 months in DicerΔoc/Δoc compared toDicerc/c.The trabeculae bone volume (BV/TV) indicates at 1 month age, an
11.4% signiﬁcant decrease compared to controls (Fig. 5B), but at
2 months BV/TVwas not signiﬁcantly different. At 2 months, trabecular
parameters were beginning to change and during the next 2 months
of growth, a 5-fold increase in BV/TV was observed. Quantitative
parameters speciﬁc for trabecular bone showed signiﬁcant increases in
Fig. 3. Dicer excision-induced defects in osteoblast differentiation occur in the cellular senescence-resistant Dicerc/c; Ink4a/Arf−/−mice. (A) SA-βGal staining of control (Ad-GFP) or
Dicer-ablated (Ad-Cre) BMSCs at day 5 shows increased senescence in the absence of Dicer. qRT-PCR analysis shows the cellular senescence marker p21. (B) BMSCs from Dicerc/c;
Ink4a/Arf−/− mice were transduced with Ad-Cre, and cultured for osteogenesis. qRT-PCR shows reduced Dicer mRNA after Ad-Cre-mediated excision, and p21 expression shows
rescue of premature cell senescence in cells lacking Dicer. Alk Phos/von Kossa staining identiﬁes reduced osteoblast differentiation from day 14 to 28 in absence of Dicer. qRT-PCR
analysis of mRNAs at days 7–21. Solid lines (——) show control Ad-GFP treated cells; dashed lines (---), Ad-Cre Dicer-ablated cells. The data are presented as mean±SD, n=3.
15T. Gaur et al. / Developmental Biology 340 (2010) 10–21the thickness (53%) and number (25%) in DicerΔoc/Δoc at 4 months and
consistent with other parameters (Fig. 5B and Supplementary Fig. S3A).
Evidence of increased cortical bone mass was found earlier at
1 month in DicerΔoc/Δoc (29% higher cortical bone area) with
decreased cortical porosity through 4 months, although not signiﬁ-
cantly changed from Dicerc/c at 8 months age (Figs. 5C, D). Other
cortical parameters reﬂected maintenance of high bone mass in the
cortex (Supplementary Fig. S4). Notably the periosteal area was more
active than the endosteal surface of the cortex in DicerΔoc/Δoc
(Supplementary Fig. 4S) which accounted for normal marrow space.
However, at 8 months the endocortical surface had a greater response
in contributing to bone formation than at earlier ages (Supplementary
Fig. S4). Overall, at 8 months when the control Dicerc/c mice have
decreased trabecular and cortical bone mass, DicerΔoc/Δoc continued
to accumulate cortical bone from 4 to 8 months (Fig. 5C).
In summary, the delayed bone formation phenotype observed in
DicerΔoc/Δoc neonates was resolved during post-natal growth and
reversed at puberty age (8 weeks). This reversal of the phenotypedocumented in long bone, lumbar and tail vertebrae is well underway
from 1 to 2 months, stabilized by 4 months and continues to increase
bone mass up to 8 months in DicerΔoc/Δoc. Although a signiﬁcantly
higher accumulation of bone tissue formedby theendochondral process
of bone formation and the periosteal surface of long bone, membranous
calvarial bone was spared from excessive bone formation.
Increased bone mass is represented by normal cellular and
tissue organization
To identify the possible changes in cellular organization of bone
tissue caused by high bone mass phenotype in absence of Dicer in
mature osteoblasts, we performed histological and molecular studies
of the femurs at 2 month age Dicerc/c and DicerΔoc/Δoc mice when the
phenotype is reversed. The Toluidine blue stained sections of cortical
bone (femur mid-shaft region shown in Fig. 6A, left panels) reveals
individual osteocytes in their lacunae with blood vessel channels
throughout in both groups, but thicker bone in DicerΔoc/Δoc mice
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bone (deposited from birth), which takes up less Toluidine blue
stain, is on the endosteal surface, while the middle zone represents
bone accumulated during rapid post-natal growth and is seen as
vascularized. The third layer of recently laid down bone formed from
the periosteal surface has rows of osteocytes in individual lacunae
with fewer blood vessel channels. This organization of new growth
more from the periosteum is supported by µCT parameters (Supple-
mentary Fig. S4). Histomorphometric quantitation of osteocytes in the
cortical bone (n=4 ﬁelds of bone along the cortex in n=3 mice)
indicates that while the total number of osteocytes is 2-fold (data not
shown) higher because of increased bone volume, the osteocyte
density per unit area is similar in Dicerc/c and DicerΔoc/Δoc (Fig. 6A,
right panel).
We had previously identiﬁed (Li et al., 2009) that a signiﬁcant
number of microRNAs are upregulated from days 21 to 28, the miner-
alization stage when the ECM is mineralized and cells are transitioned
from osteoblast to osteocytes in MC3T3 cells (Sudo et al., 1983). At
least 6 upregulated microRNAs, based on bioinformatic studies, target
collagen type I that constitutes greater than 90% of adult bone ECM.
Therefore we tested the hypothesis that a contributing mechanism to
the observed phenotype is a stimulated production of type I collagen
that accelerated the transition to osteocytes. Total cellular RNA was
prepared from long bone ﬂushed of marrow at 4 months when the
phenotype of DicerΔoc/Δoc was fully developed. qRT-PCR analyses of
multiple collagen transcripts at 4months of age revealed that the
expression of bone-speciﬁc collagens (Col1a1, Col1a2 and Col5) were
upregulated; whereas Col3a1, known to be expressed in immature
bone, is at low and equivalent levels in DicerΔoc/Δoc and Dicerc/c mice
(Fig. 6B), indicating an involvement of collagen proteins as part of the
mechanism for high bone mass in DicerΔoc/Δoc mice. Although the
Runx2 transcription was not signiﬁcantly different between the two
groups (data not shown), reﬂecting that commitment to the
osteoblast lineage is not enhanced, the Osterix transcriptional
regulator of later differentiation and osteocalcin reﬂecting a miner-
alized matrix are increased by >30% in DicerΔoc/Δoc mice. We also
examined expression of Sclerostin mRNA levels, a speciﬁc product of
osteocytes that is an inhibitor of Wnt signaling positive effects on
bone formation (ten Dijke et al., 2008). However, we ﬁnd no statistical
difference between Dicerc/c and DicerΔoc/Δoc mice (data not shown),
further indicating that osteocyte function is normal.
Several high bone mass (HBM) mouse models, such as the LRP5
activating mutation and Sclerostin null mice display an uncoupling of
bone turnover which leads to increased bone tissue deposition (Babij
et al., 2003; Li et al., 2008a). To examine this possibility in DicerΔoc/Δoc
mice, osteoclast-speciﬁc tartrate resistant acid phosphatase (TRAP)
staining was performed on bone sections from 2 month-old mice
(Fig. 6C). Overall, there is an increase in the number of osteoblasts in
the metaphyses because there is an increase in bone trabecular
surfaces. This ﬁnding suggests that bone remodeling is coupled to
ensure resorption of calciﬁed cartilage in the primary spongiosa and
conversion to lamellar fromnewly secretedwoven bone. Furthermore,
increased osteoclasts are observed in cutting cones in cortical bone of
DicerΔoc/Δoc mice to vascularize the thickened tissue (Fig. 6D). Con-
sistent with these observations, the mRNA levels of TRAP (originating
from osteoclast) and RANKL, the osteoblast coupling factor for osteo-
clast differentiation, were both upregulated in bone tissues from
DicerΔoc/Δoc mice (Fig. 6E). These ﬁndings indicate that the phenotype
of DicerΔoc/Δoc mice is not because of a reduction in bone resorption.
Rather, a coupling of increased bone remodeling to increased bone
formation is revealed.Fig. 4. In vivo excision of Dicer by OC-Cre causes perinatal skeletal deformities that differ fr
Dicerc/c (1, 3, 5) and DicerΔoc/Δoc (2, 4, 6). Alk Phos/Methyl Green staining in newborn caud
differentiation of Dicer-ablated osteoblasts (right panel) revealed by Alk Phos (left panel)
markers Runx2, Osterix, Alk Phos and OC after the proliferation period (day 7). Reduced let-7aDiscussion
Control of mesenchymal differentiation is an intricate process
requiring the interplay of cell signaling, transcription, and post-
transcriptional mechanisms. Our studies now show that miR-mediated
control of gene expression is critical for osteogenesis and bone
homeostasis. This conclusion is based on several key ﬁndings that
establish functions of Dicer in bone tissue. First, we have identiﬁed the
Dicer enzyme as essential for membranous and endochondral bone
formation in mid-stage embryos (E14.5). Second, deletion of Dicer by
OC-Cre in mature osteoblasts delayed bone formation before birth.
However, this phenotype was reversed post-natally and adult mice
showedadramatic increase inbonemass compared to controls. Third, in
theDicerΔoc/Δoc post-natal skeleton a continual accrual of trabecular and
cortical bone occurs up to age 8 months with normal bone remodeling
such that the thickened tissue is vascularized. Fourth, ex vivo studies
indicate that the cellular mechanisms which are impaired by Dicer
deletion in osteoprogenitor cells are related to post-proliferative
differentiation of committed osteoblasts. We conclude from these
observations that Dicer function is rate-limiting for the processing of
speciﬁc miRs at distinct developmental stages of bone tissue formation
in long bones and vertebral bodies. In summary, our ﬁndings suggest
that Dicer processes a distinct set of miRs in the fetal skeleton necessary
for osteogenesis, whereas in the adult skeleton miRs present in mature
osteoblasts are potent negative regulators of excessive bone formation.
Thus, Dicer produced mature miRs in osteoblast lineage cells have
potent activities in regulating cell determination, differentiation and
tissue homeostasis and exhibit a speciﬁcity for speciﬁc anatomical bone
tissues.
Mechanisms contributing to the phenotype of delayed osteoblast
differentiation before birth were revealed by ex vivo characterization
of defective cell differentiation along the osteoblast lineage. We ﬁnd
that the critical stage for which miRs are required in mesenchymal
cells occurs early in the osteoblast maturation sequence, shortly after
commitment to the osteoblast lineage. Neonatal calvarial cells from
DicerΔoc/Δoc exhibited a block in osteoblast maturation, consistent
with in vitro Dicer-ablated bone marrow derived osteoprogenitors
from Dicerc/c mice. In both cell models, Runx2 was found at
equivalent levels prior to differentiation; and, proliferation and
multi-layering of cells are not compromised, as Alk Phos positive
bone nodules are present throughout the culture. However, the
nodules are defective in their ability to mineralize, in part
compromised by further induction of Alk Phos and absence of non-
collagenous proteins (bone sialoprotein and osteocalcin) that are
normally induced in post-proliferative osteoblasts to support miner-
alization of the bone ECM (Alford and Hankenson, 2006; Malaval et
al., 2008; Robey and Boskey, 2008). These ﬁndings suggest that a
critical set of miRs must be expressed in post-proliferative osteoblasts
to indirectly activate bone-related proteins required to produce a
mineralizing ECM.
While inhibition of osteoblast differentiation is similar in ex vivo
cultured cells from our two mouse models, the striking differences in
the in vivo phenotypes can be explained by the distinct expression
patterns of the promoters used in our studies. The Col1a1 promoter is
active in pre-osteoblasts, the inner cell layer of the periosteum that
will become a bone collar (Liu et al., 2004). Thus, Dicer ablation by
Col1a1-Cre between E14.5 and E15.5, when there is a rapid induction
of mineralizing elements in control mice, compromises differentiation
of osteoprogenitor cells exhibiting Dicer loss-of-function. Osteocalcin-
Cre mice are well documented for robust activity in the post-natal
mouse (Chiang et al., 2009; Yuan et al., 2008). There are distinctom abnormalities in post-natal mice. (A) Delayed osteoblast differentiation comparing
al vertebrae (1, 2); E17.5 craniofacial regions (3, 4) and ribs (5, 6). (B) Reduced ex vivo
. (C) Mechanism of defective DicerΔoc/Δoc osteoblast maturation. Reduced osteoblast
expression and consequent upregulation of Col1a1 conﬁrm the loss of Dicer processing.
Fig. 5. High bone mass phenotype in adult mouse caused by Dicer excision by OC-Cre. (A) Femur mid-bone sagittal µCT sections show mineralized trabecular and cortical bone at the indicated ages. (B) Quantitation of trabecular bone
parameters. Reduced trabecular bone in femurs of 1 month DicerΔoc/Δoc (%BV/TV) is signiﬁcantly normalized by 2 months and signiﬁcantly increased at 4 and 8 months compared to control Dicerc/c bone. (C) Transverse scan of femurs at mid-















Fig. 6. Normal bone content in DicerΔoc/Δoc adult mice. (A) Left panels—Toluidine blue stained sections of mid-shaft cortical bone from control and DicerΔoc/Δoc femurs at age
2 months. Right panel—Normal density of osteocytes by osteocyte counts at 2 months of age. (B) Total cellular RNA prepared from 4 month age tibia bone (n=4mice per group) for
gene expression of bone-speciﬁc collagen (Col1a1, Col1a2 and Col5a3) and the immature collagen (Col3a1). (C) Increased osteoclast activity coupled to increased bone formation
shown by TRAP staining of whole femur at 2 month and (D) magniﬁed trabeculae showing TRAP positive cells. (E) Expression of TRAP and RANKL mRNA by qRT-PCR. Values are
mean±SD (n=3 mice), *p-value<0.05.
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DicerΔoc/Δoc mice. Before birth, bone formation is delayed, and ex vivo
osteoprogenitor cells from these mice exhibit a similar phenotype as
ex vivo Dicer excision of bone marrow mesenchymal cells, both
defective in differentiation to mature osteoblasts. The histology of
bone from E17.5 shows few mature osteoblasts, and suggests that the
immature cells expressing low basal osteocalcin may have different
functioning miRs than those expressed in mature osteoblasts in amineralized matrix after birth. In contrast, adult mice showed
increased bone accumulation in the appendicular skeleton and
spine, and with a normal cellular organization.
A high bone mass phenotype in DicerΔoc/Δoc was evident after
weaning initially in tail vertebrae and cortical bone. At 4 weeks age,
cortical bone in DicerΔoc/Δoc increases prior to trabecular which
becomes normal relative to Dicerc/c. This phenotype of decreased
trabecular bone, but increased cortical bone has been observed in
20 T. Gaur et al. / Developmental Biology 340 (2010) 10–21other mouse models where cortical bone compensates for weak
structure of trabecular bone (Morko et al., 2005; Turner et al., 2000).
However, beyond 2 months, a high bone mass phenotype was clearly
established which included cortical and trabecular bone of limbs and
vertebrae. Notably, the calvarium is not affected. It is possible that
excessive growth of calvarial bone may be regulated by mechanisms
other than through miRNAs which limit the size of other bones in the
body.
A striking feature of the increased bone mass of the limbs was
stimulation of newly formed bone from 1 month to after 4 months of
age occurring largely from the periosteal surfaced and more on the
lateral than the medial side of the limb. This observation suggests
two contributing mechanistic pathways that are likely to be
inﬂuenced by miRNA regulation. First, the bone extracellular matrix
harbors numerous growth factors, which contribute to both prolif-
erative expansion of pre-osteoblasts and their differentiation e.g. IGF-
1, FGFs, BMPs and TGFβ, which have been well studied (reviewed in
Allori et al. (2008); Giustina et al. (2008); Ornitz (2005)). Any
increase in their levels could potentially stimulate bone formation.
Secondly, the ﬁnding of a more profound effect on long bone
indicates that mechanical forces on the bone may in part be
contributing to the stimulated bone formation as the periosteum is
well documented for its responses to mechanical stimulation and
tissue repair (Henriksen et al., 2009). Furthermore, osteocytes are the
responsive “mechanotransducer cells” of bones (reviewed in Bone-
wald and Johnson (2008)), which can secrete factors to stimulate the
activity of the surface osteoblast (Bonewald and Johnson, 2008;
Heino et al., 2004; Hirao et al., 2007). The osteocytes are organized in
individual lacunae at a density equivalent to control. Further, bone
remodeling and osteoclast activity is not impaired and the thickened
bone becomes vascularized to maintain viability of the osteocytes.
Insight into the mechanisms for the DicerΔoc/Δoc post-natal pheno-
type of increased bone mass is obtained from our recent proﬁling
studies of miRs during osteoblast differentiation. We identiﬁed a large
representation of miRs during the mineralization period which target
collagens and proved miR-29b directly downregulated four different
collagens (Li et al., 2009). After birth, resolution of the initial delay in
bone formation followed by continuous increase in bone mass in
DicerΔoc/Δoc adult mice may be due to loss of miRs that target bone
matrix extracellular proteins. For example, we conﬁrmed in the
present studies loss of let-7a andmiR-29b and followingDicer excision
in osteoblasts and with concomitant increases in collagen levels in
bone of the DicerΔoc/Δoc mice, including the major protein of the
bone ECM (90% type I collagen). This ﬁnding of the signiﬁcance of
miR-29 in the regulation of collagen is consistent with reports in
other tissues where miR-29 decreases in myocardial infarction which
leads to ﬁbrosis (van Rooij et al., 2008). Establishment of a collagen
scaffold in bone promotes osteoblast differentiation and mineraliza-
tion (Franceschi et al., 1994; Lynch et al., 1995). In the absence of
Dicer, miRs that inhibit biosynthesis of matrix proteins are not
processed, and consequently bone formation can progress unimped-
ed to produce a greater than 2-fold increase in bone volume by
4 months that is retained up to 8 months. The process driving
osteoblasts to osteocyte maturation may arise from stimulated
secretion of ECM that accelerates the enveloping of surface
osteoblasts to further differentiate (Bonewald and Johnson, 2008).
Thus, while the Dicer enzyme is essential in early osteoprogenitors
for bone formation, excision of Dicer has an anabolic effect on the
adult skeleton due to loss of miRs that are required to regulate bone
mass.
In conclusion, our ﬁndings have now identiﬁed functions for Dicer
during development of the osteoblast phenotype for tissue morpho-
genesis and for post-natal regulation of bone accrual. These ﬁndings
provide a potential approach for stimulating bone formation with
antagomirs upon identiﬁcation of the speciﬁc microRNAs contributing
to the anabolic phenotype in adult bone.Acknowledgments
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